Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Surveillance Study of Viekira/ Exviera Tablets for Korean Hepatitis C Patients According to the Standard for "Re-examination of New Drugs"

NCT03201718 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03201718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03201718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Surveillance Study of Viekira/ Exviera Tablets for Korean Hepatitis C Patients According to the Standard for "Re-examination of New Drugs"
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
August 17, 2017
Completion date
October 11, 2019
Enrollment
505 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus (hcv)